Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline M Moore

Showing results (191-200 of 231) with videos related to

Pageof 24
Sort By:
Journal of Endourology|April 8, 2020
An Exploratory Study of Dose Escalation <i>vs</i> Standard Focal High-Intensity Focused Ultrasound for Treating Nonmetastatic Prostate CancerPhilipp M Huber, Naveed Afzal, Manit Arya, et al.
European Urology|July 2, 2018
A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate CancerStephanie Guillaumier, Max Peters, Manit Arya, et al.
BMJ Open|April 9, 2022
Histo-MRI map study protocol: a prospective cohort study mapping MRI to histology for biomarker validation and prediction of prostate cancerSaurabh Singh, Manju Mathew, Thomy Mertzanidou, et al.
The Journal of Urology|January 14, 2020
Prostate Specific Antigen Criteria to Diagnose Failure of Cancer Control following Focal Therapy of Nonmetastatic Prostate Cancer Using High Intensity Focused UltrasoundPhilipp M Huber, Naveed Afzal, Manit Arya, et al.
BJU International|January 24, 2020
Evaluation of functional outcomes after a second focal high-intensity focused ultrasonography (HIFU) procedure in men with primary localized, non-metastatic prostate cancer: results from the HIFU Evaluation and Assessment of Treatment (HEAT) registryCatherine E Lovegrove, Max Peters, Stephanie Guillaumier, et al.
Journal of the American Medical Informatics Association : JAMIA|January 20, 2022
Knowledge and insights from a maturing international clinical quality registryFanny Sampurno, Christoph Kowalski, Sarah E Connor, et al.
Radiology|August 2, 2022
Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE StudySaurabh Singh, Harriet Rogers, Baris Kanber, et al.
European Urology Focus|April 8, 2023
Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate LesionsVasilis Stavrinides, Ece Eksi, Ron Finn, et al.
European Urology|May 28, 2025
Magnetic Resonance Imaging-led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results from a Large Cohort StudyCameron Englman, Busola Adebusoye, Davide Maffei, et al.
European Urology Open Science|July 11, 2022
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 InitiativeSebastiaan Remmers, Jozien Helleman, Daan Nieboer, et al.
Pageof 24

Showing results (191-200 of 231) with videos related to

Sort By:
Pageof 24
Journal of Endourology|April 8, 2020
An Exploratory Study of Dose Escalation <i>vs</i> Standard Focal High-Intensity Focused Ultrasound for Treating Nonmetastatic Prostate CancerPhilipp M Huber, Naveed Afzal, Manit Arya, et al.
European Urology|July 2, 2018
A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate CancerStephanie Guillaumier, Max Peters, Manit Arya, et al.
BMJ Open|April 9, 2022
Histo-MRI map study protocol: a prospective cohort study mapping MRI to histology for biomarker validation and prediction of prostate cancerSaurabh Singh, Manju Mathew, Thomy Mertzanidou, et al.
The Journal of Urology|January 14, 2020
Prostate Specific Antigen Criteria to Diagnose Failure of Cancer Control following Focal Therapy of Nonmetastatic Prostate Cancer Using High Intensity Focused UltrasoundPhilipp M Huber, Naveed Afzal, Manit Arya, et al.
BJU International|January 24, 2020
Evaluation of functional outcomes after a second focal high-intensity focused ultrasonography (HIFU) procedure in men with primary localized, non-metastatic prostate cancer: results from the HIFU Evaluation and Assessment of Treatment (HEAT) registryCatherine E Lovegrove, Max Peters, Stephanie Guillaumier, et al.
Journal of the American Medical Informatics Association : JAMIA|January 20, 2022
Knowledge and insights from a maturing international clinical quality registryFanny Sampurno, Christoph Kowalski, Sarah E Connor, et al.
Radiology|August 2, 2022
Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE StudySaurabh Singh, Harriet Rogers, Baris Kanber, et al.
European Urology Focus|April 8, 2023
Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate LesionsVasilis Stavrinides, Ece Eksi, Ron Finn, et al.
European Urology|May 28, 2025
Magnetic Resonance Imaging-led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results from a Large Cohort StudyCameron Englman, Busola Adebusoye, Davide Maffei, et al.
European Urology Open Science|July 11, 2022
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 InitiativeSebastiaan Remmers, Jozien Helleman, Daan Nieboer, et al.
Pageof 24